The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders
Eating Disorders
About this trial
This is an interventional treatment trial for Eating Disorders focused on measuring Oxytocin, eating disorders, cognitive rigidity
Eligibility Criteria
Patients Inclusion Criteria: verified diagnosis of ED at least four weeks of treatment at the EDs unit Patients Exclusion Criteria: no ongoing medical care immediate suicidal or violent risk inability to complete self-report measures for any reason pregnancy according to self report Therapist Inclusion Criteria: psychologists, psychiatrists, social workers, Dieticians, and art therapist in different stages of seniority and training. Therapist Exclusion Criteria: pregnancy according to self-report.
Sites / Locations
- Shalvata Mental health Center
- Eating Disorder Clinic, Teradion
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Oxytocin
Placebo
24IU (12IU*2) of Oxytocin, Sorbitol, Benzyl, alcohol glycerol, distilled water.
24IU (12IU*2) of Sorbitol, Benzyl, alcohol glycerol, distilled water.